OncoCyte (NASDAQ:OCX) Coverage Initiated at StockNews.com
Stock analysts at StockNews.com assumed coverage on shares of OncoCyte (NASDAQ:OCX – Get Free Report) in a research report issued to clients and investors on Tuesday. The firm set a “sell” rating on the stock. Separately, Needham & Company LLC reiterated a “buy” rating and issued a $4.25 price target on shares of OncoCyte in […]
More Stories
Nobility Homes (OTCMKTS:NOBH) Posts Quarterly Earnings Results
Nobility Homes (OTCMKTS:NOBH – Get Free Report) released its quarterly earnings data on Thursday. The construction company reported $0.63 earnings...
Nobility Homes (OTCMKTS:NOBH) Posts Quarterly Earnings Results
Nobility Homes (OTCMKTS:NOBH – Get Free Report) released its quarterly earnings data on Thursday. The construction company reported $0.63 earnings...
Nexo Price Down 5.5% Over Last 7 Days (NEXO)
Nexo (NEXO) traded 1.5% higher against the US dollar during the 24 hour period ending at 12:00 PM ET on...
Nexo Price Down 5.5% Over Last 7 Days (NEXO)
Nexo (NEXO) traded 1.5% higher against the US dollar during the 24 hour period ending at 12:00 PM ET on...
BORA Price Tops $0.15 (BORA)
BORA (BORA) traded 10.8% higher against the US dollar during the 1-day period ending at 12:00 PM E.T. on January...
BORA Price Tops $0.15 (BORA)
BORA (BORA) traded 10.8% higher against the US dollar during the 1-day period ending at 12:00 PM E.T. on January...